Mickael Essouma
Mickael Essouma has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
Jean Jacques Noubiap
Division of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, Calif
5 shared publications- Jean Jacques Noubiap
Division of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, California, USA
5 shared publications - Andrea Schwarz Doria
Department of Medical Imaging, Temerty Faculty of Medicine, University of Toronto, ON, Canada
4 shared publications - Daniel Brito de Araujo
Universidade Federal de Pelotas, Brasil
4 shared publications - Edoardo Conticini
Department of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy
4 shared publications - Edoardo Marrani
Rheumatology Unit, ERN-ReCONNET Center, Meyer Children’s Hospital IRCCS, Florence, Italy
4 shared publications
Latest Publications
- 9 January 2026
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
Prevalence, incidence proportion and independent predictors of thromboembolic events in adults with antiphospholipid syndrome: A systematic review with meta-analysis
Objectives: To synthesize data on the prevalence, incidence proportion, and independent predictors of thromboembolism in adults with definite antiphospholipid syndrome (APS) and those with ‘seronegative APS’. Methods: This systematic review and meta-analysis included relevant studies published between 1 January 2000 and 27 February 2022 retrieved through electronic database (MEDLINE, EMBASE, and Web of Sciences) and hand searches. Data was synthesized narratively and through random-effects aggregate meta-analyses. Results: We summarized data from 138 studies involving 21,963 adults with APS. The pooled point prevalence of ‘APS-classifying’ thromboembolic events in the definite APS population was 74.3% for ‘general thromboembolism’, 51.3% for venous thromboembolism (VTE), and 36.0% for arterial thromboembolism. The pooled period prevalence of catastrophic APS was 2.2% and that of recurrent events was 22.3% for ‘general thromboembolism’, 8.2% for arterial thromboembolism, and 14.3% for VTE. Pooled incidence proportions during definite APS follow-up were 20.4%, 15.2%, and 8.9% for ‘general thromboembolism’, arterial thromboembolism, and VTE, respectively. Based on very low to low level of evidence, lupus anticoagulant (LA) seropositivity and hypertension were major independent predictors of VTE and arterial thromboembolism, respectively. The pooled point prevalence of ‘APS-classifying’ thromboembolic events in the ‘seronegative APS’ population was 64.8% for ‘general thromboembolism’, 19.3% for arterial thromboembolism, and 31.9% for VTE. Conclusions: We found a high burden of thromboembolism among adults with Sapporo and Sydney criteria-based APS and those with ‘seronegative APS’. Based on very low to low level of evidence, LA is potentially an independent predictor of VTE and hypertension an independent predictor of arterial thromboembolism. Additional studies with standard methods are needed to improve the existing prediction models for thromboembolism in individuals with APS.
- 9 January 2026
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
Prevalence, incidence proportion and independent predictors of thromboembolic events in adults with antiphospholipid syndrome: A systematic review with meta-analysis
Objectives: To synthesize data on the prevalence, incidence proportion, and independent predictors of thromboembolism in adults with definite antiphospholipid syndrome (APS) and those with ‘seronegative APS’. Methods: This systematic review and meta-analysis included relevant studies published between 1 January 2000 and 27 February 2022 retrieved through electronic database (MEDLINE, EMBASE, and Web of Sciences) and hand searches. Data was synthesized narratively and through random-effects aggregate meta-analyses. Results: We summarized data from 138 studies involving 21,963 adults with APS. The pooled point prevalence of ‘APS-classifying’ thromboembolic events in the definite APS population was 74.3% for ‘general thromboembolism’, 51.3% for venous thromboembolism (VTE), and 36.0% for arterial thromboembolism. The pooled period prevalence of catastrophic APS was 2.2% and that of recurrent events was 22.3% for ‘general thromboembolism’, 8.2% for arterial thromboembolism, and 14.3% for VTE. Pooled incidence proportions during definite APS follow-up were 20.4%, 15.2%, and 8.9% for ‘general thromboembolism’, arterial thromboembolism, and VTE, respectively. Based on very low to low level of evidence, lupus anticoagulant (LA) seropositivity and hypertension were major independent predictors of VTE and arterial thromboembolism, respectively. The pooled point prevalence of ‘APS-classifying’ thromboembolic events in the ‘seronegative APS’ population was 64.8% for ‘general thromboembolism’, 19.3% for arterial thromboembolism, and 31.9% for VTE. Conclusions: We found a high burden of thromboembolism among adults with Sapporo and Sydney criteria-based APS and those with ‘seronegative APS’. Based on very low to low level of evidence, LA is potentially an independent predictor of VTE and hypertension an independent predictor of arterial thromboembolism. Additional studies with standard methods are needed to improve the existing prediction models for thromboembolism in individuals with APS.
- Open Access
- 21 November 2025
- Published by Springer Nature in Advances in Rheumatology
- Vol. 65 (1) , 64
Juvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications
Background: Our review assessed whole body (WB) and dedicated body-part magnetic resonance imaging (DedMRI) techniques, protocols, and inflammatory scoring systems, focusing on their clinimetric properties (reliability, validity, responsiveness) in clinical and research settings of patients with juvenile idiopathic inflammatory myopathies (JIIM). Methods: A comprehensive search of MEDLINE, EMBASE, and Cochrane databases from 2000 to 2024 identified relevant studies. Results: Sixteen studies enrolling JIIM patients with MRI were reviewed, which showed heterogeneity in objectives, methodologies, and scoring systems. Four (25%) studies used quantitative assessments, while 12 (75%) employed semi-quantitative or qualitative methods in scoring MRI. WB-MRI was performed in 3 (18.7%) studies, and DedMRI in 13 (81.2%). Muscle evaluation included assessments of edema [14 (87.5%) studies], fatty infiltration [4 (25%) studies], and atrophy [6 (37.5%) studies]. T1 images were used in 9 (56.2%) studies for measuring chronic changes, with coronal views reported in 6 (37.5%). Fluid-sensitive sequences (T2 with fat saturation, STIR) were employed in all studies and were obtained in the coronal plane in 9 (56.2%). These sequences were crucial for detecting soft tissue edema related to acute/subacute inflammation. One (6%) study included diffusion and T1 post-contrast sequences. Conclusion: There is significant heterogeneity in MRI protocols for evaluating JIIM. Standardized WB-MRI protocols are needed to ensure consistency and comparability across studies and institutions, optimize assessments of disease activity, treatment response, and follow-up in JIIM patients. Standardization should enhance the reliability of MRI for diagnosing and monitoring JIIM in clinical and research settings.
- 21 November 2025
- Published by Springer Nature in Advances in Rheumatology
- Vol. 65 (1) , 64
Open AccessJuvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications
Background: Our review assessed whole body (WB) and dedicated body-part magnetic resonance imaging (DedMRI) techniques, protocols, and inflammatory scoring systems, focusing on their clinimetric properties (reliability, validity, responsiveness) in clinical and research settings of patients with juvenile idiopathic inflammatory myopathies (JIIM). Methods: A comprehensive search of MEDLINE, EMBASE, and Cochrane databases from 2000 to 2024 identified relevant studies. Results: Sixteen studies enrolling JIIM patients with MRI were reviewed, which showed heterogeneity in objectives, methodologies, and scoring systems. Four (25%) studies used quantitative assessments, while 12 (75%) employed semi-quantitative or qualitative methods in scoring MRI. WB-MRI was performed in 3 (18.7%) studies, and DedMRI in 13 (81.2%). Muscle evaluation included assessments of edema [14 (87.5%) studies], fatty infiltration [4 (25%) studies], and atrophy [6 (37.5%) studies]. T1 images were used in 9 (56.2%) studies for measuring chronic changes, with coronal views reported in 6 (37.5%). Fluid-sensitive sequences (T2 with fat saturation, STIR) were employed in all studies and were obtained in the coronal plane in 9 (56.2%). These sequences were crucial for detecting soft tissue edema related to acute/subacute inflammation. One (6%) study included diffusion and T1 post-contrast sequences. Conclusion: There is significant heterogeneity in MRI protocols for evaluating JIIM. Standardized WB-MRI protocols are needed to ensure consistency and comparability across studies and institutions, optimize assessments of disease activity, treatment response, and follow-up in JIIM patients. Standardization should enhance the reliability of MRI for diagnosing and monitoring JIIM in clinical and research settings.
- Open Access
- 7 November 2025
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 75, 152865
Magnetic resonance imaging for adult idiopathic inflammatory myopathies: A scoping review of protocols, grading systems and applications
- 7 November 2025
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 75, 152865
Open AccessMagnetic resonance imaging for adult idiopathic inflammatory myopathies: A scoping review of protocols, grading systems and applications
- 8 July 2024
- Published by Springer Nature in Rheumatology International
- Vol. 44 (11) , 2403-2409
A protocol for scoping reviews on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammatory myopathies
Currently, standardized magnetic resonance imaging (MRI) scoring systems and protocols for assessment of idiopathic inflammatory myopathies (IIMs) in children and adults are lacking. Therefore, we will perform a scoping review of the literature to collate and evaluate the existing semi-quantitative and quantitative MRI scoring systems and protocols for the assessment and monitoring of skeletal muscle involvement in patients with IIMs. The aim is to compile evidence-based information that will facilitate the future development of a universal standardized MRI scoring system for both research and clinical applications in IIM. A systematic search of electronic databases (PubMed, EMBASE, and Cochrane) will be undertaken to identify relevant articles published between January 2000 and October 2023. Data will be synthesized narratively. This scoping review seeks to comprehensively summarize and evaluate the evidence on the scanning protocols and scoring systems used in the assessment of diagnosis, disease activity, and damage using skeletal muscle MRI in IIMs. The results will allow the development of consensus recommendations for clinical practice and enable the standardization of research methods for the MRI assessment of skeletal muscle changes in patients with IIMs.
- 8 July 2024
- Published by Springer Nature in Rheumatology International
- Vol. 44 (11) , 2403-2409
A protocol for scoping reviews on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammatory myopathies
Currently, standardized magnetic resonance imaging (MRI) scoring systems and protocols for assessment of idiopathic inflammatory myopathies (IIMs) in children and adults are lacking. Therefore, we will perform a scoping review of the literature to collate and evaluate the existing semi-quantitative and quantitative MRI scoring systems and protocols for the assessment and monitoring of skeletal muscle involvement in patients with IIMs. The aim is to compile evidence-based information that will facilitate the future development of a universal standardized MRI scoring system for both research and clinical applications in IIM. A systematic search of electronic databases (PubMed, EMBASE, and Cochrane) will be undertaken to identify relevant articles published between January 2000 and October 2023. Data will be synthesized narratively. This scoping review seeks to comprehensively summarize and evaluate the evidence on the scanning protocols and scoring systems used in the assessment of diagnosis, disease activity, and damage using skeletal muscle MRI in IIMs. The results will allow the development of consensus recommendations for clinical practice and enable the standardization of research methods for the MRI assessment of skeletal muscle changes in patients with IIMs.
- Open Access
- 1 June 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 3 (4) , 100288
Lupus and other autoimmune diseases: Epidemiology in the population of African ancestry and diagnostic and management challenges in Africa
- 1 June 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 3 (4) , 100288
Open AccessLupus and other autoimmune diseases: Epidemiology in the population of African ancestry and diagnostic and management challenges in Africa
- Open Access
A protocol for a scoping review on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammatory myopathies
Background Currently, there is lack of standardization of magnetic resonance imaging (MRI) scoring systems and protocols for assessment of idiopathic inflammatory myopathies (IIMs) in children and adults among treatment centres across the globe. Therefore, we will perform scoping reviews of the literature to inform available semi-quantitative and quantitative MRI scoring systems and protocols for the assessment and monitoring of skeletal muscle involvement in patients with IIMs with the final goal of providing evidence-based information for the future development of a universal standardized MRI scoring system in specific research and clinical settings in this population. Methods Electronic databases (PubMed, EMBASE, and Cochrane) will be searched to select relevant articles published from January 2000 to October 2023. Data will be synthesized narratively. Discussion This scoping review will extensively map evidence on the indications, utility for diagnosis and assessment of disease activity and damage using skeletal muscle MRI in IIMs. The results will allow the development of consensus recommendations for clinical practice and enable the standardization of research methods for MRI assessment of skeletal muscle changes in patients with IIMs.
Open AccessA protocol for a scoping review on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammatory myopathies
Background Currently, there is lack of standardization of magnetic resonance imaging (MRI) scoring systems and protocols for assessment of idiopathic inflammatory myopathies (IIMs) in children and adults among treatment centres across the globe. Therefore, we will perform scoping reviews of the literature to inform available semi-quantitative and quantitative MRI scoring systems and protocols for the assessment and monitoring of skeletal muscle involvement in patients with IIMs with the final goal of providing evidence-based information for the future development of a universal standardized MRI scoring system in specific research and clinical settings in this population. Methods Electronic databases (PubMed, EMBASE, and Cochrane) will be searched to select relevant articles published from January 2000 to October 2023. Data will be synthesized narratively. Discussion This scoping review will extensively map evidence on the indications, utility for diagnosis and assessment of disease activity and damage using skeletal muscle MRI in IIMs. The results will allow the development of consensus recommendations for clinical practice and enable the standardization of research methods for MRI assessment of skeletal muscle changes in patients with IIMs.
- 15 March 2024
- Published by Elsevier in Reumatología Clínica (English Edition)
- Vol. 20 (3) , 155-161
Epidemiology of thromboembolic events in children and adolescents with antiphospholipid syndrome: A systematic review with meta-analysis
- 15 March 2024
- Published by Elsevier in Reumatología Clínica (English Edition)
- Vol. 20 (3) , 155-161
Epidemiology of thromboembolic events in children and adolescents with antiphospholipid syndrome: A systematic review with meta-analysis
- 2 January 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 553, 117742
Autoimmune inflammatory myopathy biomarkers
- 2 January 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 553, 117742
Autoimmune inflammatory myopathy biomarkers
- Open Access
- 3 May 2023
- Published by MDPI AG in Preprints.org
Acute Liver Failure Attributable to Viral Infections in Sub-Saharan Africa: A Narrative Review
Though there has been a decline in the number of new cases of viral hepatitis-induced acute liver failure in Europe and the United States of America, viral hepatitis still remains the leading cause of acute liver failure in Asia-Pacific and South America. However, the epidemiology of viral-hepatitis-induced acute liver failure in sub-Saharan Africa-the world epicenter of viral hepatitis-is unclear. The aim of this review was to collate data on the incidence, prevalence, specific etiologic agents, features/diagnosis, treatment and prognosis of viral-induced acute liver failure in sub-Saharan Africa. One hundred and forty-seven cases of viral-induced acute liver failure were recorded in 11 studies conducted in six countries between 1981-2020. Etiological agents were: Hepatitis viruses A, B, C, and E, as well as Adenovirus, Enterovirus, Parvovirus, Herpes Simplex Virus (HSV) and EBV. HAV was the most frequent in paediatric subjects: (11/16) 69% and (19/30) 63%. HBV was the only etiological agent in the study that only included adults. HEV (genotype 2 in one study) contracted amidst hepatitis E outbreaks was the most commonly reported cause of ALF in pregnant women. Treatment was mainly supportive, and liver transplantation reported only in South Africa. Where reported, case fatality rates were high. In conclusion, viral-hepatitis induced acute liver failure is largely understudied in sub-Saharan Africa. The few available data are consistent with literature from the other parts of the world regarding aetiologic agents. Liver transplantation is not available in most sub-Saharan African countries, and short-term case fatality rates of individuals with acute liver failure could outstrip current rates from the other world regions.
- 3 May 2023
- Published by MDPI AG in Preprints.org
Open AccessAcute Liver Failure Attributable to Viral Infections in Sub-Saharan Africa: A Narrative Review
Though there has been a decline in the number of new cases of viral hepatitis-induced acute liver failure in Europe and the United States of America, viral hepatitis still remains the leading cause of acute liver failure in Asia-Pacific and South America. However, the epidemiology of viral-hepatitis-induced acute liver failure in sub-Saharan Africa-the world epicenter of viral hepatitis-is unclear. The aim of this review was to collate data on the incidence, prevalence, specific etiologic agents, features/diagnosis, treatment and prognosis of viral-induced acute liver failure in sub-Saharan Africa. One hundred and forty-seven cases of viral-induced acute liver failure were recorded in 11 studies conducted in six countries between 1981-2020. Etiological agents were: Hepatitis viruses A, B, C, and E, as well as Adenovirus, Enterovirus, Parvovirus, Herpes Simplex Virus (HSV) and EBV. HAV was the most frequent in paediatric subjects: (11/16) 69% and (19/30) 63%. HBV was the only etiological agent in the study that only included adults. HEV (genotype 2 in one study) contracted amidst hepatitis E outbreaks was the most commonly reported cause of ALF in pregnant women. Treatment was mainly supportive, and liver transplantation reported only in South Africa. Where reported, case fatality rates were high. In conclusion, viral-hepatitis induced acute liver failure is largely understudied in sub-Saharan Africa. The few available data are consistent with literature from the other parts of the world regarding aetiologic agents. Liver transplantation is not available in most sub-Saharan African countries, and short-term case fatality rates of individuals with acute liver failure could outstrip current rates from the other world regions.
- 1 November 2022
- Published by Elsevier in Reumatología Clínica
- Vol. 18 (9) , 561-563
Outcomes of Pregnancy in Women With Idiopathic Inflammatory Myopathies in Africa
- 1 November 2022
- Published by Elsevier in Reumatología Clínica
- Vol. 18 (9) , 561-563
Outcomes of Pregnancy in Women With Idiopathic Inflammatory Myopathies in Africa